Fever-Tree Relabels 'Moderation' as a GBP 700M Prize — and Promises a Guaranteed 2027 Step Change

Molson Coors is finally moving the U.S. needle, but the story investors are asked to buy is a 60% EBITDA leap underwritten by a profit guarantee

FEVR.L · Earnings Call · 2026-09-10

A story that changed shape — from margin grind to guaranteed step change

For two years Fever-Tree's pitch was a margin-recovery grind: hedged glass, freight normalisation, gross margin clawing back toward historic levels. That language has been retired. The company's freshest keywords this half are step change and profit guarantee, and CFO Andy Branchflower now sells an outright inflection: “We are drawing closer now to 2027 and 2028, where we expect to see a step change in U.S., and therefore group profitability as the benefits of local U.S. production are felt, followed by a normalization in U.S. marketing investment.” — Andy Branchflower, Chief Financial Officer · 2026-09-10 He anchors that to a "circa 60% uplift in EBITDA over the next two years," insisting the quantum is "materially underpinned by guaranteed U.S. profits." The enabler is local production/onshoring: can production moves into the U.S. this autumn, trials begin now, and over half of U.S. products should be locally made next year. Contrast the prior-year keyword sets, where the top rungs were margin recovery, margin improvement and glass pricing — pure gross-margin mechanics. The engine of the story has migrated from the cost line to U.S. segmental profitability and a contractual guarantee with Molson Coors.

'Moderation' flips from headwind to the entire pitch

The genuinely company-unique thread is the relabelling of drinking moderation — long cast as an industry headwind — into Fever-Tree's central growth vector. A cluster of keywords spikes here and nowhere else in the name's history: moderation, alcohol, adult, consumers choosing, water, alongside versatility, credentials and occasion. Tim Warrillow framed the opportunity thus:

In the U.K. alone, that is around 25 million adults... This represents a value pool of around GBP 700 million. To put that into perspective, that is larger than the entire U.K. mixed category today. Yet despite its size, much of this value pool remains underserved.
Tim Warrillow, Co-Founder and CEO · 2026-09-10

This is a strategic reframe, if not yet a product pivot: a premium mixer company repositioning as a premium soft drink business, with the wider portfolio (beyond tonic) up 13% and now nearly half of group sales, supported by the diversification push that has been building for years. Reframes like this can re-rate a small-cap — provided the numbers follow.

One theme Fever-Tree clearly shares: tariff refunds

Where the company is not unique is tariffs. Tariff Refund was the market's single hottest global keyword in the prior quarter, and net tariff refunds ranks near the top again now. In the last five days alone, ASO, AEO, CULP, DBI, JILL, LAKE, LOVE, M, SIG and VNCE all booked or flagged IEEPA tariff recoveries — a genuine, broad-based sector signal across consumer names. Fever-Tree joins them, but with a twist: “U.S. tariff refunds received in the second half will offset the full-year impact of the incremental GBP 2.6 million EPR provision.” — Andy Branchflower, Chief Financial Officer · 2026-09-10 So headline EBITDA is being flattered by two offsetting one-offs: a real EPR provision (the U.K. on-trade levy) absorbed by a tariff windfall, with GBP 5.4m of provision sitting on the balance sheet and clear upside optionality if the legal challenge succeeds. Meanwhile another global current — High fuel costs, a top global decliner theme — is largely neutralised here: bottles and cans are "materially hedged" for energy through 2028. The company is riding a market-wide tax/tariff wave rather than creating one.

What's fallen away, and what to watch

Three things stand out. First, the old 15% margin target, which the company had spent years defending, is simply gone. Back in September 2023 the CFO was still pointing to “circa 600 basis point increase in gross margins... that circa 15% EBITDA, which we're comfortable we can deliver against” — Andy Branchflower, CFO · 2023-09-12 — today the same 15% is reframed as a 2027 destination gated by U.S. onshoring rather than gross-margin discipline. Second, the RTD / adult-soft-drink prize in the U.S. is explicitly deferred: Warrillow says they and Molson have agreed to focus the network on core mixers "for the next couple of years and not distract them with other opportunities," which is exactly the risk one analyst probed. Third, the distribution-deal chatter is a recurring, not new, theme — in 2024 Warrillow called RTDs "something that we are looking hard at, but nothing to announce yet" and said “we sit right at the heart of that opportunity and so ever more interesting for bigger players” — Tim Warrillow, Co-Founder and CEO · 2024-09-12. Now he says the brand is “getting more approaches than ever before” — Tim Warrillow, Co-Founder and CEO · 2026-09-10 while being "in no rush" — same music, louder. The U.K. return to growth is real but flattered by "good weather" and softer comparatives, and the on-trade remains challenged. Net: a small, asset-light compounder asking to be believed on an execution-and-guarantee story, riding a tariff tailwind the whole market is enjoying, while minting a genuinely new 'moderation' narrative of its own.